Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder by Llewellyn Mills, Adrian Dunlop, Mark Montebello, Jan Copeland, Raimondo Bruno, Meryem Jefferies, Iain Mcgregor, Nicholas Lintzeris

Get full text

Quantifying the clinical significance of cannabis withdrawal. by David J Allsop, Jan Copeland, Melissa M Norberg, Shanlin Fu, Anna Molnar, John Lewis, Alan J Budney

Get full text

Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol by Anjali K. Bhardwaj, David J. Allsop, Jan Copeland, Iain S. McGregor, Adrian Dunlop, Marian Shanahan, Raimondo Bruno, Nghi Phung, Mark Montebello, Craig Sadler, Jessica Gugusheff, Melissa Jackson, Jennifer Luksza, Nicholas Lintzeris, Agonist Replacement for Cannabis Dependence (ARCD) study group

Get full text

Reducing Cannabis Use in Young Adults With Psychosis Using iCanChange, a Mobile Health App: Protocol for a Pilot Randomized Controlled Trial (ReCAP-iCC) by Ovidiu Tatar, Amal Abdel-Baki, Anne Wittevrongel, Tania Lecomte, Jan Copeland, Pamela Lachance-Touchette, Stephanie Coronado-Montoya, José Côté, David Crockford, Simon Dubreucq, Sophie L'Heureux, Clairélaine Ouellet-Plamondon, Marc-André Roy, Philip G Tibbo, Marie Villeneuve, Didier Jutras-Aswad

Get full text